Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.
Panayiotopoulos
Chrystostomos P
CP
Benbadis
Selim R
SR
Covanis
Anthanasios
A
Dulac
Olivier
O
Duncan
John S
JS
Eeg-Olofsson
Orvar
O
Ferrie
Colin D
CD
Grünewald
Richard A
RA
Kasteleijn-Nolst Trenite
Dorothee G A
DG
Koutroumanidis
Michael
M
Martinovic
Zarko
Z
Newton
Richard W
RW
Parker
Alasdair P
AP
Salas-Puig
Janvier
J
Sander
J W A S
JW
Shorvon
Simon
S
Watanabe
Kazuyoshi
K
Whitehouse
William P
WP
Youroukos
Sotirios
S
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D004827:Epilepsy / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D009626:Terminology as Topic; D016896:Treatment Outcome
D000927:Anticonvulsants